Compare Medtronic PLC (MDT) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs PulteGroup, Inc. — how do they compare? Medtronic PLC trades at $90.61 (market cap $116.07B), while PulteGroup, Inc. trades at $132.77 (market cap $25.22B). The key difference: Medtronic PLC is far larger — about 4.6× PulteGroup, Inc.'s market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| MDT | PHM | |
|---|---|---|
Market Cap | $116.07B | $25.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $105.35 | $142.56 |
52-Week Low | $73.75 | $110.11 |
Enterprise Value | $134.82B | $25.64B |
Dividend Yield | 3.18% | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $90.70, up 1.44% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.55 beating expectations of $1.54. Revenue growth accelerated to $33.54 billion in 2025 with improving profit margins of 13.2%. Recent positive developments include new product approvals and institutional accumulation, though RSI levels suggest potential near-term overbought conditions.
The outlook remains positive with analyst consensus targeting $98.75 (8.9% upside) and no sell ratings. Key opportunities include robotic surgery platform expansion and cardiac ablation growth, while risks involve rising debt levels and competitive pressures. The stock offers dividend stability with a $0.72 upcoming payment, making it attractive for income-focused investors seeking medical technology exposure.
PulteGroup (PHM) trades at $129.35, down 0.54% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 EPS of $2.48, beating estimates, but revenue and margins face pressure. Analyst consensus is a Moderate Buy with a $137.20 price target, and recent news highlights operational expansion into Northwest Florida and workplace recognition.
The outlook remains cautiously optimistic supported by a solid balance sheet and community growth, though margin compression and housing market affordability challenges present near-term risks. The stock offers value with a P/E of 13.53, but investors should monitor earnings consistency and industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
